Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Heva Health vs MedLeanRx

Heva Health
Graded #114

Lower grade

vs+4.200000000000003
MedLeanRx
Graded #66

Higher grade

The verdict

MedLeanRx takes it — 73.9/100 to 69.7/100.

MedLeanRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
74
74
Dose & formulationMedLeanRx +41
52
93
Clinical oversightMedLeanRx +3
74
77
Labs & monitoringHeva Health +37
89
52
FulfillmentMedLeanRx +8
69
77
Contract termsEven
55
55
Heva Health · left barMedLeanRx · right bar

The numbers

MetricHeva HealthMedLeanRx
WeighScore69.7/10073.9/100
GradeCC
Scorecard rank#114#66
Semaglutide$149/mo (compounded)$149/mo (starting dose, promotional rate, compounded)
TirzepatideNot disclosed$269/mo (starting dose, compounded)
CoverageCoverage not published1 state
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
Heva Health

Graded #114 · C

Strengths

  • $149/mo entry pricing for compounded GLP-1 is competitive
  • LegitScript Certified
  • Claims licensure in all 50 states
  • Comprehensive 91-biomarker lab panel bundled — a differentiator vs compounded-GLP-1-only peers
  • Concierge care plus HRT/TRT alongside GLP-1 for an integrated longevity stack

Where it loses points

  • Tirzepatide pricing not shown — only the generic $149/mo weight-loss entry
  • Legal entity name and state of incorporation not disclosed
  • Partner pharmacy not named
  • Per-state availability not listed despite the all-50-states claim
  • Brand-name GLP-1 options (Wegovy/Zepbound/Mounjaro/Ozempic/Foundayo) not addressed
MedLeanRx

Graded #66 · C

Strengths

  • Compounded semaglutide $149/mo in both weekly injection and daily oral tablet form
  • Brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/mo fee plus medication cost
  • Intro bundle: 2 months of compounded tirzepatide (2 mg weekly) for $325 — about $163/mo
  • LegitScript seal displayed; named supervising physician (Dr. Johnson Uzor, MD)
  • Free shipping, no hidden fees, and cancel-anytime plans per homepage trust chips

Where it loses points

  • Texas only — not available in the other 49 states
  • Compounded tirzepatide is $269/mo at standard pricing, above the ~$249 market median
  • Strict no-refund policy: 'All sales are final' per Terms & Conditions
  • Pharmacy partner not publicly named — a transparency gap for a compounding service
  • Legal entity name and founding details not published on the site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard